For our Spotlight on biomarker discovery and development we carried out a survey to gain insights into biomarkers used, their challenges and future outlook.
Browsing: cerebrovascular disease
A recent study has demonstrated that overweight individuals may be more likely to survive a stroke than people of normal weight.
Couldn’t attend the 11th World Stroke Congress (17–20 October 2018, Montreal, Canada)? Find out more about the key headlines here.
Researchers have revealed that taking a simple test within a week of a stroke may help to predict the long-term prognosis of a patient; this information could be beneficial for patients when making treatment and long-term care decisions.
According to a recent study, an anti-inflammatory drug given to patients in the early stages of a stroke could reduce harmful inflammation.
This systematic review provides a summary of the blood protein biomarkers that have been studied for the diagnosis of acute ischemic stroke.
In a new study, researchers have discovered that Hi1a, a spider venom peptide, could protect the brain from stroke-induced injury by inhibiting acid-sensing ion channels in the brain.
In this editorial, the authors focus on TBIs that result in brain hemorrhage. On the battlefield, it is likely to be overlooked in favor of more readily visible injuries, yet bleeding and inflammation within the head can cause death or pervasive ongoing psychiatric conditions.
Danish study indicates that risk of depression is significantly increased following stroke, with risk highest in three months following stroke.
In this commentary, the author discusses the impact of the heart in embolic stroke with particular focus on atrial fibrillation and patent foramen ovale.